Cite
HARVARD Citation
Goel, A. et al. (2018). Cost‐effectiveness of generic pan‐genotypic sofosbuvir/velpatasvir versus genotype‐dependent direct‐acting antivirals for hepatitis C treatment. Journal of gastroenterology and hepatology. 33 (12), pp. 2029-2036. [Online].